-
About UsBPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
-
S&TInternational-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
-
Research and DevelopmentChina has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
-
BlogIntegrating industry-related media coverage as well as the company’s various activities and updates.
-
Join UsBoasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
-
A delegation led by the Cuban Ambassador to China visited Biotech Pharma.
Category:
Blog
Company News
Author:
Xu Lina
Source:
Inside the company
Release date:
2022-05-31
On May 20, Cuban Ambassador to China Carlos Miguel Pereira Hernández, Minister-Counselor Igor Montero, and First Secretary of the Economic and Commercial Section Freddy Fernández Flaqué visited Biotech Pharma. They were received by Mr. Bai Xianhong, Chairman and General Manager of Biotech Pharma.
The two sides exchanged ideas on technical cooperation and trade between Biotech Pharma and Cuba in the biopharmaceutical sector. They also discussed how Baite could foster even closer collaboration with Cuban enterprises in the future, expressing their commitment to working together for mutual development, synergy, and win-win outcomes.
Related News
Biotech pharmaceutical co., Ltd
Email: cooperation@biotechplc.com
BD Dept: bd@biotechplc.com
Address：NO.2 Rongjing East Street, Beijing Economic and Technological Development Area, Beijing 100176
Biotech pharmaceutical co., Ltd
E-mail：
Tel：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： BIOTECH PHARMACEUTICAL CO., LTD
表单验证提示文本： Content cannot be empty!
循环体没有内容时： Sorry, no matching items were found.
CSS / JS 文件放置地